AstraZeneca PLC (AZN)
184.86
+3.62
(+2.00%)
USD |
NYSE |
May 06, 16:00
184.99
+0.12
(+0.07%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 286.69B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 27.92% |
| Valuation | |
| PE Ratio | 55.52 |
| PE Ratio (Forward) | |
| PS Ratio | 9.544 |
| Price to Book Value | 6.057 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 2.151 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.7166 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 27.87% |
Profile
| N/A |
| URL | http://www.astrazeneca.com |
| Investor Relations URL | https://www.astrazeneca.com/investor-relations.html |
| HQ State/Province | Cambridgeshire |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jul. 27, 2026 |
| Last Earnings Release | Apr. 29, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 20, 2026 |
Profile
| N/A |
| URL | http://www.astrazeneca.com |
| Investor Relations URL | https://www.astrazeneca.com/investor-relations.html |
| HQ State/Province | Cambridgeshire |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jul. 27, 2026 |
| Last Earnings Release | Apr. 29, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 20, 2026 |
